| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Burrows Francis | Chief Scientific Officer | C/O KURA ONCOLOGY, INC., 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO | Teresa Bair, Attorney-in-fact for Francis Burrows | 19 Dec 2025 | 0002051119 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KURA | Common Stock | Options Exercise | $168,000 | +35,000 | +156% | $4.80 | 57,461 | 18 Dec 2025 | Direct | F1, F2 |
| transaction | KURA | Common Stock | Sale | $231,931 | -23,726 | -41% | $9.78 | 33,735 | 18 Dec 2025 | Direct | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KURA | Stock Option (Right to Buy) | Options Exercise | $0 | -35,000 | -100% | $0.000000 | 0 | 18 Dec 2025 | Common stock | 35,000 | $4.80 | Direct | F1, F4 |
| Id | Content |
|---|---|
| F1 | Cashless exercise and sale of a portion of a stock option to cover estimated payroll tax liability. |
| F2 | Includes 857 shares acquired on May 17, 2025 and 899 shares acquired on November 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan. |
| F3 | This transaction was executed in multiple trades at prices ranging from $9.77 to $9.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F4 | This option is fully vested. |